References
- Carstensen JT, Rhodes CT. (2001). Drug stability: Principles and practices. 3rd ed. New York: Marcel Dekker, Inc., 145–261.
- Grant DJW. (1999). Theory and origin of polymorphism. In: Brittain HG, ed. Polymorphism in pharmaceutical solids. New York: Marcel Dekker, Inc., 1–33.
- Buxton PC, Lynch IR, Roe JM. (1988). Solid-state forms of paroxetine hydrochloride. Int J Pharm, 42:135–43.
- Forster A, Gordon K, Schmierer D, Soper N, Wu V, Rades T. (1998). Characterization of two polymorphic forms of Ranitidine-HCl. Internet J Vib Spectrosc, 2(2):1–14.
- Kim J, Park Y, Yim Y, Han J. (1998). Crystallization behavior of hexanitrohexazaisowurtzitane at 298K and quantitative analysis of mixtures of its polymorphs by FTIR. J Chem Eng Jpn, 31(3):478–81.
- Hartauer KJ, Miller ES, Guillory JK. (1992). Diffuse reflectance infrared Fourier transform spectroscopy for the quantitative analysis of mixtures of polymorphs. Int J Pharm, 85:163–74.
- Neville GA, Beckstead HD, Shurvell HF. (1992). Utility of Fourier transform-Raman spectroscopy and Fourier transform-infrared diffuse reflectance spectroscopy for differentiation of polymorphic spirono-lactone samples. J Pharm Sci, 81(12):1141–6.
- Ritter JM, Lewis LD, Mant TGK. (1999). A textbook of clinical pharmacology. 4th ed. London: Arnold, 423–4.
- Gu XJ, Jiang W. (1995). Characterization of polymorphic forms of fluconazole using Fourier transform spectroscopy. J Pharm Sci, 84(12):1438–41.
- MacSweeney S. (1999). An examination of the polymorphic and pseudo-polymorphic behavior of fluconazole in relation to processing conditions. PhD thesis, Heriot-Watt University, UK.
- Dash AK, Elmquist WF. (2001). Fluconazole. In: Brittain, HG, ed. Analytical profiles of drug substances and excipients, vol. 27. San Diego, CA: Academic Press, 67–113.
- Alkhamis KA, Obaidat AA, Nuseirat AF. (2002). Solid-state characterization of fluconazole. Pharm Dev Technol, 7(4):491–503.
- Caira MR, Alkhamis KA, Obaidat RM. (2004). Preparation and crystal characterization of a polymorph, a monohydrate and an ethyl acetate solvate of the antifungal fluconazole. J Pharm Sci, 93(3):601–11.
- Desai SR, Shaikh MM, Dharwadkar SR. (2003). Thermoanalytical study of polymorphic transformation in fluconazole drug. Thermochim Acta, 399:81–9.
- Alkhamis KA, Salem MS, Obaidat RM. (2006). Comparison between dehydration and desolvation kinetics of fluconazole monohydrate and fluoconazole ethylacetate solvate using three different methods. J Pharm Sci, 95(4):859–70.
- Byrn SR, Pfeiffer RR, Stowell JG. (1999). Reaction kinetics: In solid-state chemistry of drugs. 2nd ed. West Lafayette, IN: SSCI Inc., 443–60.
- Vyazovkin S, Wight CA. (1998). Isothermal and non-isothermal kinetics of thermally stimulated reactions of solids. Int Rev Phys Chem, 17(3):407–33.
- Chan HK, Doelker E. (1985). Polymorphic transformation of some drugs under compression. Drug Dev Ind Pharm, 11(2&3):315–32.
- Himuro I, Tsuda Y, Sekiguchi K, Horikoshi I, Kanke M. (1971). Studies on the method of size reduction of medicinal compounds. IV. Solvate formation of chloramphenicol and its application to size reduction. Chem Pharm Bull, 19(5):1034–40.
- Gu C, Young Jr V, Grant DJW. (2001). Polymorph screening: Influence of solvents on the rate of solvent-mediated polymorphic transformation. J Pharm Sci, 90(11):1878–89.